(Press-News.org) Boston, MA – The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 26-29, 2010, in Boston, MA.
Featuring more than 305 scientific research sessions, 594 posters, and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking science and medical news. Reporters will have access to the latest research and clinical advances in the field of otolaryngology – head and neck surgery.
Information for the Media
The AAO-HNSF Annual Meeting & OTO EXPO Newsroom will be located in the Boston Convention and Exhibition Center, Room 052. Hours of operation: Saturday, September 25, 12 pm to 5 pm; Sunday-Tuesday, September 26 – 28, 7:30 am to 5 pm; and Wednesday, September 29, 7:30 am to 2 pm. The newsroom serves as a work space for credentialed members of the news media. The newsroom is managed and staffed by the AAO-HNS Communications Unit. Please see the AAO-HNS website for media credentialing requirements for the event. To register and view advance press releases, log onto the AAO-HNS website at http://am2010.entnet.org/attendees/press.cfm.
Innovations in Cleft Lip Repair: A Multicenter Perspective
Presenters: Travis Tollefson, MD (moderator); Craig Senders, MD; Sherard Tatum, MD; Tom Wang, MD; Jonathan Sykes, MD
Time: 8:00 am
Location: Room 258
Boston, MA – Novel approaches in the management of children with cleft lip and palate have contributed to a variety of treatment paradigms. Cleft and craniofacial teams with both pediatric otolaryngology and facial plastic surgery backgrounds continue to develop new methods in cleft lip repair.
In a seminar presented at the 2010 American Academy of Otolaryngology – Head and Neck Surgery Foundation Annual Meeting & OTO EXPO in Boston, researchers revealed recently published modifications of the microform, unilateral, and bilateral cleft lip repair. They also noted other innovations that seek to improve the aesthetic outcome, such as the subunit approach, suture choice, tissue glue, and scar prevention.
From their findings, researchers noted that different institutions have different approachs to common problems in management of the cleft lip and nasal deformity. The authors support the goals of the Specialty Surgery Committee of the AAFPRS in fostering collaboration between cleft surgeons within the pediatric otolaryngology and the facial plastic surgery subspecialties.
What's New in Implantable Hearing Devices
Presenters: William Slattery, MD (moderator); Craig Buchman, MD; Jose Fayad, MD; Cliff Megerian, MD; John Dornhoffer, MD
Time: 9:30 am
Location: Room 253
Boston, MA – The past ten years have seen the introduction of new devices for treatment of sensorineural hearing loss and innovations being made in cochlear implant technology.
In a paper presented at the 2010 American Academy of Otolaryngology – Head and Neck Surgery Foundation Annual Meeting & OTO EXPO in Boston, researchers sought to explore current cochlear implant technology, as well as an overview of technology in development.
The current FDA-approved devices were presented at the seminar, with a brief overview of the products in development, and FDA trials most likely to have a significant impact on patients' hearing loss.
The researchers noted that the general otolaryngologist should be able to understand implant systems available for treatment of mild to moderate sensorineural hearing loss.
Cultural Competency, Health Disparities & Health Literacy
Presenters: Duane Taylor, MD (moderator); Lisa Perry-Gilkes, MD; Ronald Kuppersmith, MD, MBA; Phyllis Bouvier, MD
Time: 10:30
Location: Room 157
Boston, MA – A new study suggests that health literacy, cultural competency, and health disparities apply to patients of all diverse backgrounds in an ever-changing, more diverse population.
In a seminar presented at the 2010 American Academy of Otolaryngology – Head and Neck Surgery Foundation Annual Meeting & OTO EXPO in Boston, researchers revealed that there can be cultural, gender, language, literacy, religious, sexual orientation, racial, ethnic, and socioeconomic disparities in hearing impairment.
The authors noted that patient interactions and enhanced advocacy will improve cultural competency perspectives and health literacy in their offices, as well as aid in understanding different cultural and religious backgrounds.
###
About the AAO-HNS
The American Academy of Otolaryngology – Head and Neck Surgery (www.entnet.org), one of the oldest medical associations in the nation, represents more than 11,000 physicians and allied health professionals who specialize in the diagnosis and treatment of disorders of the ears, nose, throat, and related structures of the head and neck. The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues. The organization's vision: "Empowering otolaryngologist-head and neck surgeons to deliver the best patient care."
Effect of Waiting Room Time on Ambulatory Satisfaction
Presenters: Clifford Bleustein, MD, MBA; Eduardas Valaitis, PhD; Raleigh Jones, MD, MBA
Time: 9:38 am
Location: Room 259AB
Boston, MA – Self-reported patient wait times alone significantly impacts all measured aspects of the ambulatory patient experience, as seen in survey responses.
In a presentation at the 2010 AAO-HNSF Annual Meeting & OTO EXPO in Boston, researchers conducted a survey between January 1 and December 31, 2008 for the University of Kentucky Health System. Data collected across 12 questions were ...
DENVER — A new test could reliably detect early increases in prostate specific antigen (PSA) levels — a biomarker commonly used to measure the recurrence of prostate cancer — in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.
Data measuring the efficacy of this new test were presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
"AccuPSA is a ...
DENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.
Tina B. Edmonston, M.D., director of the clinical laboratory at Rosetta Genomics, Inc., presented data on the assay at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held here.
Lung cancers are traditionally divided into two main groups, either neuroendocrine or non-small cell lung cancer. In 20 to 30 percent ...
DENVER — A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity.
"Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup," said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S.
Nielsen presented the results at the Fourth AACR International Conference on Molecular Diagnostics in Cancer ...
DENVER — Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer.
Analyzing CTCs in blood can identify cancer cells and cancer cell mutations to provide physicians with methods for improved cancer diagnosis, prognosis and treatment.
In order to efficiently capture CTCs, two capture mechanisms were used to trap CTCs by antibody affinity and size. ...
ST. PAUL, Minn. – New research shows that an intravenous (IV) treatment may cut a person's risk of dying from bacterial meningitis. The research is published in the September 29, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. The treatment is called dexamethasone.
"Using this treatment in people infected with meningitis has been under debate because in a few large studies it was shown to be ineffective," said study author Diederik van de Beek, MD, PhD, with the Academic Medical Center, University of Amsterdam in the Netherlands ...
In two landmark studies published today in the journal Drug Testing and Analysis (DTA), UK and Swiss research teams reveal two techniques proven to identify dissolved cocaine in bottles of wine or rum. These tools will allow customs officials to quickly identify bottles being used to smuggle cocaine, without the need to open or disturb the container.
Cocaine is among the most common drugs of abuse and a large number of imaginative techniques of smuggling cocaine through border controls have been reported in recent years. One of the latest techniques involves smuggling ...
Cold Spring Harbor, NY -- The story of the double helix's discovery has a few new twists. A new primary source -- a never-before-read stack of letters to and from Francis Crick, and other historical materials dating from the years 1950-76 -- has been uncovered by two professors at the Watson School of Biological Sciences at Cold Spring Harbor Laboratory (CSHL).
The letters both confirm and extend current knowledge of the circumstances surrounding the epoch-making discovery of DNA's elegant double-helical structure, for which Crick, James D. Watson (now CSHL's chancellor ...
###
Grants from the National Institutes of Health and the Food and Drug Administration supported the immunotherapy study. Grants from the National Cancer Institute, part of the National Institutes of Health, supported the study of intermediate-risk neuroblastoma. Both studies were conducted through the Children’s Oncology Group.
“Anti-GD2 Antibody with GM-CSF, Interleukin-2 and Isotretinoin for Neuroblastoma,” and “Outcome after Reduced Chemotherapy for Intermediate Risk Neuroblastoma,” New England Journal of Medicine, Sept. 30, 2010.
About The Children’s Hospital ...
EDITOR'S NOTE: Images to accompany this story are available at http://www.news.wisc.edu/newsphotos/river-crisis.html END ...
